Grantable
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) · National Institutes of Health
up to $150,000 Due in 40 days
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innova…
Ask me anything about applying to this grant — your fit, eligibility, or how to start your narrative.
One free message · powered by Grantable AI
Welcome to Grantable
Sign in to start building your grant-ready profile
or
We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.